Published in Virology on June 01, 1995
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Theiler's virus infection of perforin-deficient mice. J Virol (1998) 1.19
Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J Virol (1996) 1.19
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol (1997) 1.14
High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol (2001) 1.10
Theiler's murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells. J Virol (2009) 1.07
Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. J Virol (1999) 1.03
Theiler's virus-induced intrinsic apoptosis in M1-D macrophages is Bax mediated and restricts virus infectivity: a mechanism for persistence of a cytolytic virus. J Virol (2008) 1.01
Interaction of Theiler's virus with intermediate filaments of infected cells. J Virol (1998) 1.01
Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions. J Virol (2003) 1.00
Theiler's virus infection of primary cultures of bone marrow-derived monocytes/macrophages. J Virol (2002) 0.96
Infection of macrophages by Theiler's murine encephalomyelitis virus is highly dependent on their activation or differentiation state. J Virol (1997) 0.95
Amino acid substitutions in VP2 residues contacting sialic acid in low-neurovirulence BeAn virus dramatically reduce viral binding and spread of infection. J Virol (2003) 0.92
The role of myelin in Theiler's virus persistence in the central nervous system. PLoS Pathog (2007) 0.90
The GDVII strain of Theiler's virus spreads via axonal transport. J Virol (1999) 0.88
Avian reovirus major mu-class outer capsid protein influences efficiency of productive macrophage infection in a virus strain-specific manner. J Virol (2001) 0.85
A critical role for virus-specific CD8(+) CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice. Virology (2010) 0.82
Hematopoietic cell activation in the subventricular zone after Theiler's virus infection. J Neuroinflammation (2008) 0.80
SHP-1-dependent macrophage differentiation exacerbates virus-induced myositis. J Immunol (2015) 0.77
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection. J Virol (2013) 0.76
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy. J Neuroimmunol (2017) 0.75
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Popular films do not reflect current tobacco use. Am J Public Health (1994) 3.10
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Theiler's virus-induced demyelination: prevention by immunosuppression. Science (1976) 2.59
Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res (2000) 2.58
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry (1991) 2.30
Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology (1988) 2.11
Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TEMV-specific delayed-type hypersensitivity. J Immunol (1985) 2.06
In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nat Med (1998) 1.98
Computer-based drug-utilization review--risk, benefit, or boondoggle? N Engl J Med (1995) 1.91
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology (1990) 1.90
Theiler's murine encephalomyelitis virus group includes two distinct genetic subgroups that differ pathologically and biologically. J Virol (1981) 1.87
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol (1982) 1.81
Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol (1986) 1.76
Multiple sclerosis. Animal model:Theiler's virus infection in mice. Am J Pathol (1977) 1.73
Speciation of cone snails and interspecific hyperdivergence of their venom peptides. Potential evolutionary significance of introns. Ann N Y Acad Sci (1999) 1.69
Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J Immunol (1984) 1.67
Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology (1984) 1.62
Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses. Infect Immun (1978) 1.55
Substance abuse vulnerability and D2 receptor genes. Trends Neurosci (1993) 1.55
Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci (1976) 1.52
Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence. J Virol (1980) 1.52
Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun (1979) 1.50
Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci U S A (1992) 1.50
Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis (1978) 1.46
Analysis of genetic variation in Theiler's virus during persistent infection in the mouse central nervous system. Virology (1983) 1.46
The sobering D2 story. Science (1994) 1.39
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
Pseudotumor cerebri syndrome without papilledema. JAMA (1972) 1.36
Characterization of Vilyuisk virus as a picornavirus. J Med Virol (1983) 1.35
Replication of Theiler's murine encephalomyelitis viruses in BHK21 cells: an electron microscopic study. Virology (1980) 1.35
Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect Immun (1977) 1.33
Managing the pharmacy benefit in Medicare HMOs: what do we really know? Health Aff (Millwood) (2000) 1.30
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend (1993) 1.27
Nucleotide sequence identifies Vilyuisk virus as a divergent Theiler's virus. Virology (1992) 1.26
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb Pathog (1987) 1.24
Cap-independent translation by the 5' untranslated region of Theiler's murine encephalomyelitis virus. J Virol (1992) 1.24
Cellular immunity in chronic Theiler's virus central nervous system infection. J Immunol (1976) 1.24
The TO strains of Theiler's viruses cause "slow virus-like" infections in mice. Ann Neurol (1979) 1.23
Comparison of the binding characteristics to BHK-21 cells of viruses representing the two Theiler's virus neurovirulence groups. Virology (1991) 1.21
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4. Rev Infect Dis (1987) 1.21
The structure of a highly virulent Theiler's murine encephalomyelitis virus (GDVII) and implications for determinants of viral persistence. Virology (1996) 1.20
Theiler's murine encephalomyelitis virus kills restrictive but not permissive cells by apoptosis. J Virol (1996) 1.19
Fidelity of in vitro transcription of T3 deoxyribonucleic acid by bacteriophage T3-induced ribonucleic acid polymerase and by Escherichia coli ribonucleic acid polymerase. J Biol Chem (1974) 1.16
Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol (1997) 1.16
Post-translationally modified neuropeptides from Conus venoms. Eur J Biochem (1999) 1.15
Anticerebellar antibodies in serum and cerebrospinal fluid of a patient with oat cell carcinoma of the lung and paraneoplastic cerebellar degeneration. Ann Neurol (1986) 1.14
Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus. Am J Pathol (1980) 1.12
No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. JAMA (1994) 1.12
Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines. J Virol (1991) 1.11
High numbers of viral RNA copies in the central nervous system of mice during persistent infection with Theiler's virus. J Virol (2001) 1.10
A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J Virol (1998) 1.10
Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J Neurol Sci (1979) 1.10
Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion. Proc Natl Acad Sci U S A (1988) 1.08
The T-superfamily of conotoxins. J Biol Chem (1999) 1.07
The spasmodic peptide defines a new conotoxin superfamily. Biochemistry (2000) 1.07
Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide. Proc Natl Acad Sci U S A (1999) 1.07
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J Neuroimmunol (1990) 1.06
Evidence for an umbrella mechanism of bilayer transport. J Am Chem Soc (2001) 1.06
The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J Virol (1995) 1.05
Differentiation of M1 myeloid precursor cells into macrophages results in binding and infection by Theiler's murine encephalomyelitis virus and apoptosis. J Virol (1999) 1.03
The pathogenesis of rat virus infections in the newborn hamster. Lab Invest (1972) 1.01
Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol (1990) 1.00
Characterization of Theiler's murine encephalomyelitis virus RNA. J Gen Virol (1982) 0.99
Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther (2013) 0.98
Acute transverse myelopathy in adults. A follow-up study. Arch Neurol (1973) 0.98
Restricted Theiler's murine encephalomyelitis virus infection in murine macrophages induces apoptosis. J Gen Virol (1999) 0.95
Reduced leucine-enkephalin--like immunoreactive substance in hamster basal ganglia after long-term ethanol exposure. Science (1982) 0.95
Do-not-resuscitate decisions in a community hospital. Incidence, implications, and outcomes. JAMA (1986) 0.95
Evolution of community-based arsenic removal systems in remote villages in West Bengal, India: assessment of decade-long operation. Water Res (2010) 0.95
Whole brain methionine-enkephalin of ethanol-avoiding and ethanol-preferring c57BL mice. Experientia (1982) 0.94
Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J Virol (1993) 0.94
Mutation of predicted virion pit residues alters binding of Theiler's murine encephalomyelitis virus to BHK-21 cells. J Virol (2000) 0.93
Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler's murine encephalomyelitis virus. J Virol (1998) 0.93
Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplant (2004) 0.93
The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C. J Neuroimmunol (1987) 0.92
Naloxone-induced inhibition of ethanol dependence in mice. Nature (1977) 0.90
Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins. J Gen Virol (1987) 0.90
The growth of four human and animal enteroviruses in the central nervous systems of mice. J Neuropathol Exp Neurol (1981) 0.89
The new england journal of medicine. N Engl J Med (1983) 0.88
Calcutta metro: is it safe from noise pollution hazards? Ind Health (1996) 0.88
Ethanol acceptance as a function of genotype amounts of brain [Met]enkephalin. Proc Natl Acad Sci U S A (1983) 0.88
Theiler's virus-specified polypeptides made in BHK-21 cells. J Gen Virol (1984) 0.88
Enhancement of alcohol withdrawal convulsions in mice by haloperidol. Clin Toxicol (1976) 0.85
Rationale and dose-finding studies of the combination of irinotecan and a taxane on a weekly schedule. Oncology (Williston Park) (2001) 0.85
Location and distribution of virus antigen in the central nervous system of mice persistently infected with Theiler's virus. Br J Exp Pathol (1983) 0.85
[Influence of minimum volumes on the structure of inpatient care]. Gesundheitswesen (2008) 0.85
Opiate-like activity of salsolinol on the electrically stimulated guinea pig ileum. Life Sci (1979) 0.85
The effects of 5-HTP on para-Chlorophenylalanine (p-CPA) attenuation of "conflict" behavior. Eur J Pharmacol (1970) 0.85
[Hospitals failing minimum volumes in 2004: reasons and consequences]. Gesundheitswesen (2008) 0.85
Informing parents about mental retardation: a study of professional communication and parent acceptance. Soc Sci Med (1977) 0.85
Neurodynamics of relapse prevention: a neuronutrient approach to outpatient DUI offenders. J Psychoactive Drugs (1990) 0.84